Solve Leadership Honors Top Immunologist and Presents Solve Together Real-World Data Platform
Solve CSO Tim Hsiao, Director of Advancement Ilise Friedman, Dr. Akiko Iwasaki, and Solve President Emily Taylor Solve President and CEO Emily Taylor, Chief Scientific Officer H. Timothy Hsiao, and […]
Key Takeaways from NASEM’s “Long Term Health Effects of COVID-19: Disability and Function Following SARS-COV-2 Infection” Report
The National Academies of Sciences, Engineering, and Medicine (NASEM), a nongovernmental institution that advises federal agencies on science and medicine, has released its report, “Long Term Health Effects of COVID-19: […]
Solve M.E. Announces Emily Taylor as New President and CEO and Publication of New White Paper Calling for NIH to Restructure Funding for ME/CFS, Long Covid, and other IACCIs
Solve M.E. is pleased to announce that Emily Taylor, Vice President of Advocacy and Engagement, has been appointed as President and CEO. Emily has been a key member of Solve’s […]
Solve Releases New White Paper: A Home for Infection-Associated Chronic Conditions and Illnesses (IACCIs) at NIH
Complementing our Advocacy Week 2024 efforts, Solve has co-authored a new white paper, “A Home for Infection-Associated Chronic Conditions and Illnesses (IACCIs) at NIH.” Co-written by Solve President and CEO […]
Solve VP of Advocacy Emily Taylor talks to STAT About the Push For a New Coordinating Mechanism at NIH for Infection-Associated Chronic Conditions
On March 15, Long Covid Awareness Day, Solve’s VP of Advocacy and Engagement Emily Taylor was quoted by STAT in its coverage of the push for a new office at […]
Susannah Fox Will be the Keynote Speaker for Solve’s 2024 EmPOWER M.E. Event
As part of Advocacy Week 2024, our EmPOWER M.E. roundtable on April 19 at 9 am PT / 12 pm ET will feature panels of patient advocates, professionals, and scientists […]
Solve Responds to Findings From the NIH Intramural ME/CFS Clinical Study Published in “Nature”
Findings from the National Institutes of Health (NIH) intramural ME/CFS clinical study were published in Nature Communications last week to mixed reception by the patient advocate community. Co-written by 75 […]
January 2024 Advocacy Cafe Chat
Join us for this month’s Advocacy Cafe Chat! In this session, Solve’s Vice President of Advocacy and Engagement Emily Taylor will review our recently updated Policy Advocacy Statement, which drives […]
Solve Joins Broad Coalition Urging President Biden to Address Crisis of Infection-Associated Chronic Conditions in FY25 Budget
Solve joined a coalition of more than 80 clinicians, researchers, RECOVER PIs, and patient and disability organizations in sending an open letter to President Biden urging him to address the […]
October Advocacy Cafe
Join us for this month’s Advocacy Cafe Chat! This session will be your chance to provide input on our Policy Advocacy Statement. We are about to begin updating the statement, […]
Uniting Voices: The Journey from Long COVID Alliance to IACC-PAC
Dear Solve Community, As Vice President of Advocacy and Engagement, I’m excited to share our remarkable journey in uniting voices, forging connections, and expanding our community. In 2021, Solve co-founded […]
Emily Taylor co-authors American Journal of Medicine article on Long Covid and ME/CFS
Solve Vice President of Advocacy and Engagement Emily Taylor is co-author of “What Long Covid Investigators Can Learn From Four Decades of ME/CFS Research,” which was recently published in The […]
